Oral indomethacin versus oral ibuprofen for treatment of patent ductus arteriosus: a randomised controlled study in very low-birthweight infants
© 2018 Informa UK Limited, trading as Taylor & Francis Group Background: In low- and middle-income countries (LMIC), haemodynamically significant patent ductus arteriosus (hsPDA) is treated with oral indomethacin (IDC) and ibuprofen (IB) instead of intravenous formulations. No significant diff...
Saved in:
Main Authors: | Varangthip Khuwuthyakorn, Chuleeporn Jatuwattana, Suchaya Silvilairat, Watcharee Tantiprapha |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048786251&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/58890 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity
by: Varaporn Sangtawesin, et al.
Published: (2018) -
Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: A randomized trial at Ramathibodi Hospital
by: Sarayut Supapannachart, et al.
Published: (2018) -
Reply to letter to the editor: “Comparison of efficacy and safety of oral ibuprofen versus oral indomethacin”
by: Varangthip Khuwuthyakorn, et al.
Published: (2019) -
291 Impact of patent ductus arteriosus (PDA) on postnatal growth and cognition of very low birthweight infants
by: Lee, Le Ye, et al.
Published: (2022) -
Effectiveness and safety of high dose oral ibuprofen versus standard dose for treatment of preterm infants with patent ductus arteriosus
by: Yaowaret Mekkhayai, et al.
Published: (2018)